CTEV vs REGN · rev $930.6M vs P/E 14, rev $14.34B
Claritev Corporation (CTEV) versus Regeneron Pharmaceuticals Inc (REGN) — a side-by-side from cached financials, not a winner call.
Claritev Corporation (CTEV) is a health information services company listed on US.
Regeneron Pharmaceuticals Inc (REGN) is a biotechnology company listed on US.
Latest reported CTEV revenue for 2024-12-31 was $930.6M. Net income was -$1.65B. Revenue was down 3.2% from 2023-12-31 to 2024-12-31. CTEV currently screens at market cap $440.5M.
Latest reported REGN revenue for 2025-12-31 was $14.34B. Net income was $4.50B. Revenue was up 1.0% from 2024-12-31 to 2025-12-31. REGN currently screens at market cap $59.10B and trailing P/E 13.9.
CTEV currently screens at market cap $440.5M. REGN currently screens at market cap $59.10B and trailing P/E 13.9.
Not investment advice. Open the CTEV and REGN stock pages for the full models.
Not investment advice.